Search bioRxiv⌕ Search

Biology subjects

Amona, I.

Publications and source records attributed to Amona, I..

3 recordsLinked to original sources

Continental-scale survey of Treponema pallidum in African nonhuman primates: expanding the range to the Mediterranean basin

Background: Treponema pallidum, the causative agent of yaws, bejel, and syphilis, is a significant pathogen affecting both humans and nonhuman primates (NHPs). While its presence is documented in several African NHP species, the continental-scale distribution, ecological drivers, and status in North African populations remain poorly understood. We conducted a large-scale, non-invasive survey to investigate the circulation of T. pallidum across African NHP populations and evaluate geographical and ecological patterns of exposure. Results: A total of 1,696 fecal samples from 11 wild NHP species collected across five African countries were screened for anti-T. pallidum antibodies using an automated chemiluminescent Simple Western assay, and fecal and dipteran samples were analyzed by molecular methods. Widespread seropositivity was observed across all African sites and multiple primate taxa, including great apes and cercopithecids. We provide the first evidence of T. pallidum antibodies in Barbary macaques (Macaca sylvanus) from North Africa, extending the known distribution of the pathogen to the Mediterranean basin. In West Africa, chimpanzees (Pan troglodytes verus) from Senegal and Guinea exhibited particularly high seroprevalence, confirming this region as a major endemic hotspot. In Central Africa, substantial circulation was documented in Cercopithecus wolfi, Cercopithecus ascanius, and western lowland gorillas (Gorilla gorilla gorilla). Arid/savanna biomes showed significantly higher exposure than Mediterranean and tropical rainforest biomes. No T. pallidum DNA was detected in fecal or dipteran samples. Conclusion: Our findings demonstrate widespread circulation of T. pallidum among African NHPs, reveal its presence in North African primate populations for the first time. The observed high seroprevalence, coupled with significant variations across species and geographical regions, suggests the existence of multiple transmission pathways adapted to specific host behaviors and environmental constraints. These results support the existence of a broad multihost sylvatic reservoir and provide new insights into the ecology of T. pallidum, with important implications for wildlife health, One Health surveillance, and yaws eradication efforts.

microbiology↗

Silent Footprints of Ebolavirus in the Forest: Serological Clues from Wild Non-Human Primates in the Democratic Republic of Congo

Filoviruses, particularly Ebola virus (EBOV), remain a major public health concern in Central Africa. However, their circulation in wildlife during inter-epidemic periods remains poorly documented. Non-human primates (NHPs) may serve as ecological sentinels of viral dynamics at human-forest interfaces, yet surveillance is constrained by the limitations of invasive sampling. We conducted a non-invasive investigation of EBOV exposure in free-ranging NHPs from the Mabali Forest Reserve (Equateur Province, Democratic Republic of Congo) for Ebola virus disease. A total of 630 fecal samples were collected and screened for active infection by PCR targeting the EBOV nucleoprotein gene; all samples tested negative. Molecular identification of host species was achieved in 569 samples (90.3%). Fecal serology using an automated capillary western blot platform (JESS), targeting EBOV nucleoprotein, glycoprotein and viral protein 40 antigens, identified four seropositive individuals (0.70%), including two Cercopithecus ascanius and two C. wolfi. The detection of discrete immunoreactive bands consistent with EBOV-specific antibodies suggests prior exposure despite the absence of active outbreaks. These findings provide the first serological evidence compatible with EBOV exposure in these two Cercopithecus species and support the hypothesis of low-level or cryptic viral circulation in forest ecosystems. The study highlights the feasibility and value of fecal serology as a non-invasive One Health surveillance tool for monitoring zoonotic pathogens at wildlife-human interfaces.

microbiology↗

Stool serology: development of a non-invasive immunological method for the detection of Enterovirus-specific antibodies in Congo gorilla feces

The incidence of poliovirus has significantly reduced by as much as 99.9% globally. Alongside this, however, vaccine-associated paralytic poliomyelitis has emerged. Recently, a new recombinant virus (Enterovirus C/Poliovirus) was identified in humans working as eco-guards and in gorillas in Democratic Republic of Congo, including one gorilla with polio-like sequelae. A strain of this recombinant virus (Ibou002) was also isolated from gorilla faeces. In order to assess the potential role of poliovirus infection, we have developed and optimised a protocol, based on the lyophilisation and solubilisation of small volumes of stool extracts, to detect specific antibodies. First, total immunoglobulins was detected in the concentrated stool extracts. Specific antibodies were then detected in 4/16 gorilla samples and 2/3 human samples by western blot using both the polio vaccine antigen and the Ibou002 antigen and by ELISA using the polio vaccine antigen. Humoral responses were greater with the Ibou002 antigen. We therefore suggest that this recombinant virus could lead to a polio-like disease in the endangered western lowland gorilla. The development of a non-invasive method to detect microorganism-specific immunoglobulins from faecal samples opens up new perspectives for the exploration of humoral responses of pathogens in animals and a greater understanding of zoonotic infectious diseases.

microbiology↗